Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

AI-BLADE toolbox: AI-powered BLADdEr multiparametric MRI analysis for clinical application.

BJR artificial intelligence·2026
Same author

Clinical and genomic profiling of early-onset bladder cancer identifies key alterations and therapeutic targets.

medRxiv : the preprint server for health sciences·2026
Same author

Urinary Biomarkers Objectively Measure Minimal Residual Disease in Non-Muscle-Invasive Bladder Cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

Neoadjuvant Nivolumab with or without Ipilimumab for Cisplatin-Ineligible Patients with Muscle-Invasive Bladder Cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

Neoadjuvant Chemotherapy for High-risk Localized Upper Tract Urothelial Carcinoma: Final Long-term Outcomes from a Phase 2 Clinical Trial and an Expanded Cohort.

European urology·2025
Same author

Evaluating Benefits of Peristomal Mesh Placement at the Time of Radical Cystectomy and Ileal Conduit Formation: A Phase 3, Randomized Controlled Trial.

The Journal of urology·2025

Related Experiment Video

Updated: Jan 19, 2026

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
12:45

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer

Published on: February 12, 2022

6.4K

Lymph Node Dissection for Advanced Bladder Cancer: Is There a Role?

Bernard H Bochner1

  • 1Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

European Urology Focus
|September 26, 2019
PubMed
Summary

Radical cystectomy with pelvic lymph node dissection is crucial for high-risk bladder cancer. Selected patients with advanced retroperitoneal lymph node disease may benefit from surgical resection.

More Related Videos

Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy
05:52

Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy

Published on: August 19, 2021

13.0K
The Role of Anatomical Dissection in Defining Colic and Small Bowel Artery Lymphovascular Bundles in the D3 Volume of Small and Large Bowel Mesentery
05:43

The Role of Anatomical Dissection in Defining Colic and Small Bowel Artery Lymphovascular Bundles in the D3 Volume of Small and Large Bowel Mesentery

Published on: August 1, 2025

635

Related Experiment Videos

Last Updated: Jan 19, 2026

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
12:45

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer

Published on: February 12, 2022

6.4K
Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy
05:52

Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy

Published on: August 19, 2021

13.0K
The Role of Anatomical Dissection in Defining Colic and Small Bowel Artery Lymphovascular Bundles in the D3 Volume of Small and Large Bowel Mesentery
05:43

The Role of Anatomical Dissection in Defining Colic and Small Bowel Artery Lymphovascular Bundles in the D3 Volume of Small and Large Bowel Mesentery

Published on: August 1, 2025

635

Area of Science:

  • Urology
  • Surgical Oncology

Background:

  • Radical cystectomy is a standard treatment for high-risk bladder cancer.
  • Pelvic lymph node dissection (PLND) is a critical component of radical cystectomy.
  • The role of extended lymphadenectomy for advanced nodal disease requires further clarification.

Purpose of the Study:

  • To evaluate the role and outcomes of surgical resection for advanced retroperitoneal lymph node involvement in bladder cancer patients undergoing radical cystectomy.

Main Methods:

  • Review of cases undergoing radical cystectomy with pelvic lymph node dissection.
  • Selection criteria included limited retroperitoneal nodal disease, response to systemic therapy, and resectability.
  • Analysis of oncologic outcomes and complications.

Main Results:

  • Selected patients with advanced retroperitoneal lymph node disease can achieve benefit from surgical resection.
  • Careful patient selection is paramount for successful outcomes.

Conclusions:

  • Thorough pelvic lymph node dissection is essential for quality surgical care in high-risk bladder cancer.
  • Surgical resection may be a beneficial option for select patients with advanced retroperitoneal nodal disease.